Summary
- Current Price
- As of today, NKTR price is $36.95, down -4.94% on
- Current Price All-Time High
- NKTR price is currently -97.79% below its historical high of $1,670.40 set on
- Market Cap
- NKTR current market cap is $1B, down -1.13% year-over-year
- Revenue
- NKTR current annual revenue is $55.23M, down -43.89% year-over-year
- Next Earnings
- The next earnings release for NKTR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Nektar Therapeutics |
| Ticker | NASDAQ: NKTR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nektar.com |
| Employees | 61 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $36.95 | |
| Price, 1D Change | -4.94% | |
| $1B | ||
| - | ||
| - | ||
| 1.03 | ||
| $55.23M | ||
| Revenue, 1Y Change | -43.89% | |
| -$9.73 | ||
| EPS, 1Y Change | -12.09% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$9.73 | ||
| EPS Estimate | -$8.08 | N/A |
| EPS Est. Change | +16.88% | N/A |
| $55.23M | ||
| Revenue Estimate | $41.82M | N/A |
| Revenue Est. Change | -24.28% | N/A |
| Current Price | $36.95 | |
| Price Target | $150.00 | - |
| Price Tgt. Change | +305.95% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.80 | -$8.68 | -984.56% | |
| -$9.37 | -$9.73 | -3.79% | |
| -$8.08 | N/A | +16.88% | |
| -$10.50 | N/A | -8.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $105.92M | $98.43M | -7.08% | |
| $43.78M | $55.23M | +26.15% | |
| $41.82M | N/A | -24.28% | |
| $53.42M | N/A | -3.29% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $36.95 | |
| $65.02 | ||
| $54.94 | ||
| $58.98 | ||
| $50.53 | ||
| -$4.51 | ||
| 1.03 | ||
| $2.30 | ||
| 31.25 | ||
| 53.51% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $55.23M | ||
| -$9.73 | ||
| $55.23M | ||
| 98.14% | ||
| -$130.77M | ||
| -236.77% | ||
| -$164.08M | ||
| -297.07% | ||
| -$133.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 1.66 | ||
| 4.97 | ||
| 4.97 | ||
| - | ||
| 3 | ||
| -15.23 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 23.11 | ||
| 1.40 | ||
| -5.49 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $89.83M | ||
| $245.75M | ||
| $280.41M | ||
| $266.27M | ||
| $190.57M | ||
| $53.54M | ||
| $148.91M | ||
| $20.50M | ||
| $10.77M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $219.31M | ||
| $186.00M | ||
| $1.03M | ||
| $0.00 | ||
| $1.03M | ||
| $0.00 | ||
| -$138.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$208.51M | ||
| -$1.20M | ||
| $180.57M | ||
| $171.00K | ||
| -$208.68M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | ||
| Leerink Partners | ||
| Raymond James | ||
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| Wedbush | → | |
| BTIG | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
No data
Screeners with NKTR
FAQ
- What is the ticker symbol for Nektar Therapeutics?
- The ticker symbol for Nektar Therapeutics is NASDAQ:NKTR
- Does Nektar Therapeutics pay dividends?
- No, Nektar Therapeutics does not pay dividends
- What sector is Nektar Therapeutics in?
- Nektar Therapeutics is in the Healthcare sector
- What industry is Nektar Therapeutics in?
- Nektar Therapeutics is in the Biotechnology industry
- What country is Nektar Therapeutics based in?
- Nektar Therapeutics is headquartered in United States
- When did Nektar Therapeutics go public?
- Nektar Therapeutics initial public offering (IPO) was on May 3, 1994
- Is Nektar Therapeutics in the S&P 500?
- No, Nektar Therapeutics is not included in the S&P 500 index
- Is Nektar Therapeutics in the NASDAQ 100?
- No, Nektar Therapeutics is not included in the NASDAQ 100 index
- Is Nektar Therapeutics in the Dow Jones?
- No, Nektar Therapeutics is not included in the Dow Jones index
- When was Nektar Therapeutics last earnings report?
- Nektar Therapeutics's most recent earnings report was on August 13, 2026
- When does Nektar Therapeutics report earnings?
- The next expected earnings date for Nektar Therapeutics is November 12, 2026
Data Sources & References
- NKTR Official Website www.nektar.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm
- NKTR Profile on Yahoo Finance finance.yahoo.com/quote/NKTR
- NKTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nktr
